Alain Buisson - Publications

Affiliations: 
Université de Caen, Cyceron, Caen, Normandie, France 
Area:
stroke, NMDA, alzheimer

59 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Perrio C, Nicole O, Buisson A. GluN2B Subunit Labeling with Fluorescent Probes and High-Resolution Live Imaging. Methods in Molecular Biology (Clifton, N.J.). 1677: 171-183. PMID 28986873 DOI: 10.1007/978-1-4939-7321-7_9  0.72
2014 Gouix E, Buisson A, Nieoullon A, Kerkerian-Le Goff L, Tauskela JS, Blondeau N, Had-Aissouni L. Oxygen glucose deprivation-induced astrocyte dysfunction provokes neuronal death through oxidative stress. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 87: 8-17. PMID 24928737 DOI: 10.1016/j.phrs.2014.06.002  1
2014 Becerril-Ortega J, Bordji K, Fréret T, Rush T, Buisson A. Iron overload accelerates neuronal amyloid-β production and cognitive impairment in transgenic mice model of Alzheimer's disease. Neurobiology of Aging. 35: 2288-301. PMID 24863668 DOI: 10.1016/j.neurobiolaging.2014.04.019  1
2014 Frandemiche ML, De Seranno S, Rush T, Borel E, Elie A, Arnal I, Lanté F, Buisson A. Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-beta oligomers. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 6084-97. PMID 24760868 DOI: 10.1523/JNEUROSCI.4261-13.2014  1
2014 Rush T, Buisson A. Reciprocal disruption of neuronal signaling and Aβ production mediated by extrasynaptic NMDA receptors: a downward spiral. Cell and Tissue Research. 356: 279-86. PMID 24496511 DOI: 10.1007/s00441-013-1789-1  1
2013 Dhilly M, Becerril-Ortega J, Colloc'h N, MacKenzie ET, Barré L, Buisson A, Nicole O, Perrio C. Synthesis and in vitro characterisation of ifenprodil-based fluorescein conjugates as GluN1/GluN2B N-Methyl-D-aspartate receptor antagonists. Chembiochem : a European Journal of Chemical Biology. 14: 759-69. PMID 23532918 DOI: 10.1002/cbic.201200675  1
2013 Burnouf S, Martire A, Derisbourg M, Laurent C, Belarbi K, Leboucher A, Fernandez-Gomez FJ, Troquier L, Eddarkaoui S, Grosjean ME, Demeyer D, Muhr-Tailleux A, Buisson A, Sergeant N, Hamdane M, et al. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model. Aging Cell. 12: 11-23. PMID 23082852 DOI: 10.1111/acel.12018  1
2012 El Gaamouch F, Buisson A, Moustié O, Lemieux M, Labrecque S, Bontempi B, De Koninck P, Nicole O. Interaction between αCaMKII and GluN2B controls ERK-dependent plasticity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 10767-79. PMID 22855824 DOI: 10.1523/JNEUROSCI.5622-11.2012  1
2012 Montagne A, Gauberti M, Macrez R, Jullienne A, Briens A, Raynaud JS, Louin G, Buisson A, Haelewyn B, Docagne F, Defer G, Vivien D, Maubert E. Ultra-sensitive molecular MRI of cerebrovascular cell activation enables early detection of chronic central nervous system disorders. Neuroimage. 63: 760-70. PMID 22813950 DOI: 10.1016/j.neuroimage.2012.07.018  1
2012 Kervern M, Angeli A, Nicole O, Léveillé F, Parent B, Villette V, Buisson A, Dutar P. Selective impairment of some forms of synaptic plasticity by oligomeric amyloid-β peptide in the mouse hippocampus: implication of extrasynaptic NMDA receptors. Journal of Alzheimer's Disease : Jad. 32: 183-96. PMID 22785392 DOI: 10.3233/JAD-2012-120394  1
2012 Marchand P, Becerril-Ortega J, Mony L, Bouteiller C, Paoletti P, Nicole O, Barré L, Buisson A, Perrio C. Confocal microscopy imaging of NR2B-containing NMDA receptors based on fluorescent ifenprodil-like conjugates. Bioconjugate Chemistry. 23: 21-6. PMID 22148315 DOI: 10.1021/bc100571g  1
2011 Bordji K, Becerril-Ortega J, Buisson A. Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer's disease. Reviews in the Neurosciences. 22: 285-94. PMID 21568789 DOI: 10.1515/RNS.2011.029  1
2011 Labas R, Gilbert G, Nicole O, Dhilly M, Abbas A, Tirel O, Buisson A, Henry J, Barré L, Debruyne D, Sobrio F. Synthesis, evaluation and metabolic studies of radiotracers containing a 4-(4-[18F]-fluorobenzyl)piperidin-1-yl moiety for the PET imaging of NR2B NMDA receptors. European Journal of Medicinal Chemistry. 46: 2295-309. PMID 21453995 DOI: 10.1016/j.ejmech.2011.03.013  1
2010 Bordji K, Becerril-Ortega J, Nicole O, Buisson A. Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-ß production. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 15927-42. PMID 21106831 DOI: 10.1523/JNEUROSCI.3021-10.2010  1
2010 Bouteiller C, Becerril-Ortega J, Marchand P, Nicole O, Barré L, Buisson A, Perrio C. Copper-catalyzed amination of (bromophenyl)ethanolamine for a concise synthesis of aniline-containing analogues of NMDA NR2B antagonist ifenprodil. Organic & Biomolecular Chemistry. 8: 1111-20. PMID 20165802 DOI: 10.1039/b923255a  1
2009 Gouix E, Léveillé F, Nicole O, Melon C, Had-Aissouni L, Buisson A. Reverse glial glutamate uptake triggers neuronal cell death through extrasynaptic NMDA receptor activation. Molecular and Cellular Neurosciences. 40: 463-73. PMID 19340933 DOI: 10.1016/j.mcn.2009.01.002  1
2008 Léveillé F, El Gaamouch F, Gouix E, Lecocq M, Lobner D, Nicole O, Buisson A. Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 4258-71. PMID 18711223 DOI: 10.1096/fj.08-107268  1
2008 Dulin F, Léveillé F, Ortega JB, Mornon JP, Buisson A, Callebaut I, Colloc'h N. P3 peptide, a truncated form of A beta devoid of synaptotoxic effect, does not assemble into soluble oligomers. Febs Letters. 582: 1865-70. PMID 18474239 DOI: 10.1016/j.febslet.2008.05.002  1
2007 Vandame D, Desmadryl G, Becerril Ortega J, Teigell M, Crouzin N, Buisson A, Privat A, Hirbec H. Comparison of the pharmacological properties of GK11 and MK801, two NMDA receptor antagonists: towards an explanation for the lack of intrinsic neurotoxicity of GK11. Journal of Neurochemistry. 103: 1682-96. PMID 17908242 DOI: 10.1111/j.1471-4159.2007.04925.x  1
2005 Lesné S, Ali C, Gabriel C, Croci N, MacKenzie ET, Glabe CG, Plotkine M, Marchand-Verrecchia C, Vivien D, Buisson A. NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 9367-77. PMID 16221845 DOI: 10.1523/JNEUROSCI.0849-05.2005  1
2005 Lesné S, Gabriel C, Nelson DA, White E, Mackenzie ET, Vivien D, Buisson A. Akt-dependent expression of NAIP-1 protects neurons against amyloid-{beta} toxicity. The Journal of Biological Chemistry. 280: 24941-7. PMID 15797869 DOI: 10.1074/jbc.M413495200  1
2004 Liot G, Benchenane K, Léveillé F, López-Atalaya JP, Fernández-Monreal M, Ruocco A, Mackenzie ET, Buisson A, Ali C, Vivien D. 2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 24: 1153-9. PMID 15529015 DOI: 10.1097/01.WCB.0000134476.93809.75  1
2004 Abraini JH, David HN, Nicole O, MacKenzie ET, Buisson A, Lemaire M. Neuroprotection by nitrous oxide and xenon and its relation to minimum alveolar concentration. Anesthesiology. 101: 260-1; author reply . PMID 15220810  1
2004 Liot G, Gabriel C, Cacquevel M, Ali C, MacKenzie ET, Buisson A, Vivien D. Neurotrophin-3-induced PI-3 kinase/Akt signaling rescues cortical neurons from apoptosis. Experimental Neurology. 187: 38-46. PMID 15081586 DOI: 10.1016/j.expneurol.2004.01.002  1
2004 Fernández-Monreal M, López-Atalaya JP, Benchenane K, Léveillé F, Cacquevel M, Plawinski L, MacKenzie ET, Bu G, Buisson A, Vivien D. Is tissue-type plasminogen activator a neuromodulator? Molecular and Cellular Neurosciences. 25: 594-601. PMID 15080889 DOI: 10.1016/j.mcn.2003.11.002  1
2003 David HN, Leveille F, Chazalviel L, MacKenzie ET, Buisson A, Lemaire M, Abraini JH. Reduction of ischemic brain damage by nitrous oxide and xenon. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 23: 1168-73. PMID 14526227 DOI: 10.1097/01.WCB.0000087342.31689.18  1
2003 Buisson A, Lesne S, Docagne F, Ali C, Nicole O, MacKenzie ET, Vivien D. Transforming growth factor-beta and ischemic brain injury. Cellular and Molecular Neurobiology. 23: 539-50. PMID 14514014 DOI: 10.1023/A:1025072013107  1
2003 Docagne F, Ali C, Lesne S, Nicole O, MacKenzie ET, Buisson A, Vivien D. [Does transforming growth factor-beta (TGF-beta) act as a neuroprotective agent in cerebral ischemia?]. Journal De La SociéTé De Biologie. 197: 145-50. PMID 12910629  1
2003 Matys T, Strickland S. Tissue plasminogen activator and NMDA receptor cleavage. Nature Medicine. 9: 371-2; author reply . PMID 12669038 DOI: 10.1038/nm0403-371  1
2003 Lesné S, Docagne F, Gabriel C, Liot G, Lahiri DK, Buée L, Plawinski L, Delacourte A, MacKenzie ET, Buisson A, Vivien D. Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice. The Journal of Biological Chemistry. 278: 18408-18. PMID 12626500 DOI: 10.1074/jbc.M300819200  1
2003 Gabriel C, Ali C, Lesné S, Fernández-Monreal M, Docagne F, Plawinski L, MacKenzie ET, Buisson A, Vivien D. Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 277-9. PMID 12490542 DOI: 10.1096/fj.02-0403fje  1
2002 Docagne F, Nicole O, Gabriel C, Fernández-Monreal M, Lesné S, Ali C, Plawinski L, Carmeliet P, MacKenzie ET, Buisson A, Vivien D. Smad3-dependent induction of plasminogen activator inhibitor-1 in astrocytes mediates neuroprotective activity of transforming growth factor-beta 1 against NMDA-induced necrosis. Molecular and Cellular Neurosciences. 21: 634-44. PMID 12504596 DOI: 10.1006/mcne.2002.1206  1
2002 Chuquet J, Benchenane K, Liot G, Fernández-Monreal M, Toutain J, Blanchet S, Eveno E, Auffray C, Piétu G, Buisson A, Touzani O, MacKenzie ET, Vivien D. Matching gene expression with hypometabolism after cerebral ischemia in the nonhuman primate. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 22: 1165-9. PMID 12368653 DOI: 10.1097/00004647-200210000-00002  1
2002 Lesné S, Blanchet S, Docagne F, Liot G, Plawinski L, MacKenzie ET, Auffray C, Buisson A, Piétu G, Vivien D. Transforming growth factor-beta1-modulated cerebral gene expression. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 22: 1114-23. PMID 12218417 DOI: 10.1097/00004647-200209000-00009  1
2001 Docagne F, Colloc'h N, Bougueret V, Page M, Paput J, Tripier M, Dutartre P, MacKenzie ET, Buisson A, Komesli S, Vivien D. A soluble transforming growth factor-beta (TGF-beta ) type I receptor mimics TGF-beta responses. The Journal of Biological Chemistry. 276: 46243-50. PMID 11544249 DOI: 10.1074/jbc.M010915200  1
2001 Ali C, Docagne F, Nicole O, Lesné S, Toutain J, Young A, Chazalviel L, Divoux D, Caly M, Cabal P, Derlon JM, MacKenzie ET, Buisson A, Vivien D. Increased expression of transforming growth factor-beta after cerebral ischemia in the baboon: an endogenous marker of neuronal stress? Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 21: 820-7. PMID 11435794 DOI: 10.1097/00004647-200107000-00007  1
2001 Nicole O, Ali C, Docagne F, Plawinski L, MacKenzie ET, Vivien D, Buisson A. Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 3024-33. PMID 11312287  1
2001 van Beek J, Nicole O, Ali C, Ischenko A, MacKenzie ET, Buisson A, Fontaine M. Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death. Neuroreport. 12: 289-93. PMID 11209937  1
2001 Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, Vivien D, Buisson A. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nature Medicine. 7: 59-64. PMID 11135617 DOI: 10.1038/83358  1
2000 Ali C, Nicole O, Docagne F, Lesne S, MacKenzie ET, Nouvelot A, Buisson A, Vivien D. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 20: 956-66. PMID 10894179 DOI: 10.1097/00004647-200006000-00008  1
2000 Vivien D, Buisson A. Serine protease inhibitors: novel therapeutic targets for stroke? Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 20: 755-64. PMID 10826525 DOI: 10.1097/00004647-200005000-00001  1
1999 Ruocco A, Nicole O, Docagne F, Ali C, Chazalviel L, Komesli S, Yablonsky F, Roussel S, MacKenzie ET, Vivien D, Buisson A. A transforming growth factor-beta antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 19: 1345-53. PMID 10598939 DOI: 10.1097/00004647-199912000-00008  1
1999 Docagne F, Nicole O, Marti HH, MacKenzie ET, Buisson A, Vivien D. Transforming growth factor-beta1 as a regulator of the serpins/t-PA axis in cerebral ischemia. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 13: 1315-24. PMID 10428756  1
1998 Buisson A, Nicole O, Docagne F, Sartelet H, Mackenzie ET, Vivien D. Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor beta1. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 12: 1683-91. PMID 9837858  1
1998 Vivien D, Bernaudin M, Buisson A, Divoux D, MacKenzie ET, Nouvelot A. Evidence of type I and type II transforming growth factor-beta receptors in central nervous tissues: changes induced by focal cerebral ischemia. Journal of Neurochemistry. 70: 2296-304. PMID 9603194  1
1997 Yu SP, Sensi SL, Canzoniero LM, Buisson A, Choi DW. Membrane-delimited modulation of NMDA currents by metabotropic glutamate receptor subtypes 1/5 in cultured mouse cortical neurons. The Journal of Physiology. 499: 721-32. PMID 9130168  1
1996 Buisson A, Yu SP, Choi DW. DCG-IV selectively attenuates rapidly triggered NMDA-induced neurotoxicity in cortical neurons. The European Journal of Neuroscience. 8: 138-43. PMID 8713457 DOI: 10.1111/j.1460-9568.1996.tb01174.x  1
1995 Buisson A, Choi DW. The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death. Neuropharmacology. 34: 1081-7. PMID 8532157 DOI: 10.1016/0028-3908(95)00073-F  1
1994 Boulu RG, Plotkine M, Buisson A. [Nitric monoxide, a new neurotransmitter in the central nervous system]. Annales Pharmaceutiques FrançAises. 52: 69-80. PMID 7944182  1
1994 Verrecchia C, Buisson A, Lakhmeche N, Plotkine M, Boulu RG. Nitric oxide and cerebral ischemia. Annals of the New York Academy of Sciences. 738: 341-7. PMID 7530421  1
1994 Lancelot E, Callebert J, Buisson A, Plotkine M, Boulu RG. The role of dopamine on the vulnerability of the ischemic striatum | ROLE DE LA DOPAMINE DANS LA VULNERABILITE DU STRIATUM A L'ISCHEMIE Circulation Et Metabolisme Du Cerveau. 11: 299-302.  1
1994 Buisson A, Callebert J, Plotkine M, Boulu RG. Role of dopamine on the consequences of rat experimental focal ischaemia | ETUDE DU ROLE DE LA DOPAMINE DANS LES CONSEQUENCES DE L'ISCHEMIE FOCALE EXPERIMENTALE CHEZ LE RAT Circulation Et Metabolisme Du Cerveau. 11: 267-293.  1
1993 Buisson A, Margaill I, Callebert J, Plotkine M, Boulu RG. Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia. Journal of Neurochemistry. 61: 690-6. PMID 7687658  1
1993 Buisson A, Lakhmeche N, Verrecchia C, Plotkine M, Boulu RG. Nitric oxide: an endogenous anticonvulsant substance. Neuroreport. 4: 444-6. PMID 7684618  1
1992 Buisson A, Plotkine M, Boulu RG. The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia. British Journal of Pharmacology. 106: 766-7. PMID 1382786  1
1992 Buisson A, Callebert J, Mathieu E, Plotkine M, Boulu RG. Striatal protection induced by lesioning the substantia nigra of rats subjected to focal ischemia. Journal of Neurochemistry. 59: 1153-7. PMID 1353789  1
1991 Nonnotte L, Buisson A, Nagy F, Moulins M. Combination of horseradish peroxidase and lucifer yellow staining for selective labeling of neurons at the electron microscopic level. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 39: 1579-83. PMID 1918933  1
1991 Buisson A, Pateau V, Plotkine M, Boulu RG. Nigrostriatal pathway modulates striatum vulnerability to quinolinic acid. Neuroscience Letters. 131: 257-9. PMID 1837072 DOI: 10.1016/0304-3940(91)90627-6  1
1991 Buisson A, Plotkine M, Boulu R. Lesioning the substantia nigra reduces striatal infarct volume following focal ischemia in rats. Fundamental & Clinical Pharmacology. 5: 645-7. PMID 1778543  1
Show low-probability matches.